Internal Medicine
Review: Insulin therapy for the non-specialist physician.
27 Jul, 2021 | 03:18h | UTCInsulin therapy for the non-specialist physician – Clinical Medicine Journal
Review: Diabetes and the kidney.
27 Jul, 2021 | 03:16h | UTCDiabetes and the kidney – Clinical Medicine Journal
Review: Managing hyperglycemia in inpatients.
27 Jul, 2021 | 03:21h | UTCManaging hyperglycaemia in inpatients – Clinical Medicine Journal
[Preprint] RCT: In patients with COVID-19 and severe hypoxia, dexamethasone 12 mg did NOT result in statistically significant improved outcomes compared to dexamethasone 6 mg – “Mortality at 28 days was 27.1% and 32.3% in patients assigned to 12 mg and 6 mg, respectively (adjusted relative risk 0.86, 99% CI, 0.68-1.08)”.
26 Jul, 2021 | 03:01h | UTC
Review: Uncommon forms of diabetes.
27 Jul, 2021 | 03:14h | UTCUncommon forms of diabetes – Clinical Medicine Journal
Large cohort study finds one in two hospitalized COVID-19 patients develop a complication.
26 Jul, 2021 | 03:00h | UTCCommentaries:
In-hospital complications associated with COVID-19 – The Lancet
CV Complications Common in Hospitalized COVID-19 Patients – TCTMD
Almost Half of Patients Admitted With COVID-19 Have Complications – HealthDay
Commentary on Twitter (thread – click for more)
NEW—An observational study of >70,000 people in the UK hospitalised with severe #COVID19 finds 1 in 2 developed at least one health complication. Authors warn of significant challenges for individuals and health & social care in the coming years.
🔗 https://t.co/CTLsPJcGZ7 pic.twitter.com/voMEDVXO9U
— The Lancet (@TheLancet) July 15, 2021
Study: Lateral flow antigen testing can rapidly and accurately detect early COVID-19 among patients presenting with flu-like illness and can be a plausible alternative to RT-PCR.
26 Jul, 2021 | 02:56h | UTCNews release: Lateral flow tests are 95% effective at detecting Covid-19 when used at the onset of symptoms – University of Oxford
Related:
Rapid point-of-care tests for diagnosing COVID-19 infection: the latest Cochrane evidence
Commentary on Twitter (thread – click for more)
Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2)
Thread on today's @EDGEclinical paper, with some recommendations at the end for how we can improve UK testing. 🧵
— The Sharing Scientist (@ScienceShared) July 14, 2021
M-A: Psychiatric patients at increased risk of COVID-19 hospitalization and mortality.
26 Jul, 2021 | 02:57h | UTCNews release: Psychiatric patients at increased risk of COVID-19 hospitalization and mortality – European College of Neuropsychopharmacology
Study: Among kidney transplant recipients who did not respond after 2 doses, a third dose of an mRNA-1273 vaccine induced a serologic response in 49% of patients.
26 Jul, 2021 | 02:54h | UTCCommentary: Case Mounts for COVID Vaccine Boosters in Kidney Transplant Recipients – MedPage Today (free registration required)
Related:
[Preprint] 3rd AstraZeneca shot gives strong immunity.
Commentary on Twitter
JUST PUBLISHED @JAMANetwork
✔️N=159 kidney #transplant recipients
✔️3rd dose of #mRNA #Moderna #vaccine induced a #serologic response in 49% of kidney transplant recipients who did not respond after 2 doseshttps://t.co/NCDyraI98x#RealTimeCOVID19 @IDSAInfo @HIV_TID @AST_info— COVID-19 Real-Time Learning Network (RTLN) (@RealTimeCOVID19) July 24, 2021
Case report: Kawasaki-like multisystem inflammatory syndrome associated with SARS-CoV-2 infection in an adult.
26 Jul, 2021 | 02:52h | UTCRelated:
Case report: Multisystem inflammatory syndrome in an adult after SARS-CoV-2 infection.
Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection
Case Reports: 2 Adults with Kawasaki-like Multisystem Inflammatory Syndrome Associated with COVID-19
Position paper: Advancing precision medicine for acute respiratory distress syndrome.
26 Jul, 2021 | 02:28h | UTCRelated:
Review: Personalized mechanical ventilation in acute respiratory distress syndrome.
Seminar | Acute respiratory distress syndrome.
ARDS: Contemporary management and novel approaches during COVID-19
Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.
26 Jul, 2021 | 02:22h | UTCDietary carbohydrates and fats in nonalcoholic fatty liver disease – Nature Reviews Gastroenterology & Hepatology (free for a limited period)
Commentary on Twitter
A Review published in @NatRevGastroHep discusses the role of dietary fats and carbohydrates in the pathogenesis of nonalcoholic fatty liver disease. https://t.co/QSYLruuXGt pic.twitter.com/3FoQjZoNOO
— Nature Portfolio (@NaturePortfolio) July 22, 2021
Clinical practice guidelines for the medical management of Graves’ orbitopathy.
26 Jul, 2021 | 02:26h | UTC
Editorial | Antibiotic overuse: managing uncertainty and mitigating against overtreatment.
26 Jul, 2021 | 02:16h | UTCAntibiotic overuse: managing uncertainty and mitigating against overtreatment – BMJ Quality & Safety
Commentary on Twitter
Our editorial in @BMJ_Qual_Saf discusses uncertainty and antibiotic overuse, and identifies 4 strategies to address the tendency to prescribe 'just in case'. @EM_Krockow https://t.co/kvIG5uxxOL pic.twitter.com/eTIuqGOj1o
— Prof Carolyn Tarrant (@carolynctarrant) July 21, 2021
Cohort study: Higher intake of ultra-processed food linked to increased risk of inflammatory bowel disease.
26 Jul, 2021 | 02:13h | UTCCommentaries:
Ultra-processed food linked to higher risk of IBD – BMJ
International study links ultra-processed foods with IBD risk – Medical News Today
M-A of cohort studies: Meat consumption and risk of ischemic heart disease.
26 Jul, 2021 | 02:09h | UTCCommentary: Red and processed meat linked to increased risk of heart disease, Oxford study shows – Oxford University
Opinion | Tocilizumab in COVID-19 therapy: who benefits, and how? – the researchers suggest that maybe IL-6 inhibitors should be given only to patients with high IL-6.
23 Jul, 2021 | 10:51h | UTCTocilizumab in COVID-19 therapy: who benefits, and how? – The Lancet
Related: A living WHO guideline on drugs for covid-19 – interleukin-6 receptor blockers are now recommended for patients with severe or critical covid-19. AND M-A: Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 – “The 4% absolute risk reduction in mortality from 25% to 21% with IL-6 inhibition added to glucocorticoids may not translate to patients with a lower baseline mortality risk and likely do not justify the additional expense and risk for toxicities for patients hospitalized with modest oxygen requirements and a stable clinical course (from editorial)”. AND RECOVERY trial: In hospitalized COVID-19 patients with hypoxia and systemic inflammation (C-reactive protein ≥75 mg/L), tocilizumab improved survival and other clinical outcomes AND Secondary analysis of RCT finds Tocilizumab was beneficial to patients hospitalized with Covid-19 if CRP levels were greater than 15.0 mg/dL, but not if CRP levels were 15.0 mg/dL or less. AND M-A: Tocilizumab in COVID-19 – “For hospitalized COVID-19 patients, there is some evidence that tocilizumab use may be associated with a short-term mortality benefit, but further high-quality data are required”.
What are the Delta, Gamma, Beta and Alpha Covid variants?
23 Jul, 2021 | 10:45h | UTCWhat are the Delta, Gamma, Beta and Alpha Covid variants? – BBC
Related: Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”. AND WHO renames COVID-19 variants with the Greek alphabet (i.e., Alpha, Beta, Gamma, etc), making them simple, easy to say and remember. The naming system aims to prevent calling COVID-19 variants by the places where they are detected, which is stigmatizing & discriminatory.
Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients.
23 Jul, 2021 | 10:47h | UTC
New series from The Lancet: Physical Activity 2021.
23 Jul, 2021 | 10:37h | UTCHomepage: Physical Activity 2021 – The Lancet (free registration required for all articles)
Summary and commentary: Experts call for immediate action to ensure physical activity is built into everyday lives – News Medical
Commentary on Twitter (thread – click for more)
🆕 In the early stages of the #pandemic, #PhysicalActivity was considered *essential* for health by many governments—but inactivity remains a major issue.
Ahead of #Tokyo2020, we launch @TheLancet #PhysicalActivity21 Series 🤸♀️👨🦽
Access here: https://t.co/j0GhLGKAAD pic.twitter.com/mrcOnRPyR6
— The Lancet (@TheLancet) July 22, 2021
How the Delta variant achieves its ultrafast spread – “Viral load is roughly 1,000 times higher in people infected with the Delta variant than those infected with the original coronavirus strain, according to a study in China”.
23 Jul, 2021 | 10:46h | UTCHow the Delta variant achieves its ultrafast spread – Nature
CDC releases new guidelines for the treatment of sexually transmitted infections.
23 Jul, 2021 | 10:41h | UTCTable of Contents: Sexually Transmitted Infections Treatment Guidelines, 2021
Related (just released): WHO Guidelines for the management of symptomatic sexually transmitted infections.
Commentary on Twitter (thread – click for more)
Here's my greatest hits from today’s new @CDCSTD #STI Treatment Guidelines: a 🧵
1)#STI guidelines instead of #STD!
2)Expedited Partner Therapy: not just for “heterosexuals” 👏
3)#HepatitisC: screen all pregnant people
4)Rectal/throat GC/CT: consider for non-MSM like teens 👏 pic.twitter.com/gfEhrWpMKA— Ina Park (@InaParkMD) July 22, 2021
Review: Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit.
23 Jul, 2021 | 10:30h | UTC
Position Statement on Endomyocardial Biopsy.
23 Jul, 2021 | 10:33h | UTC
Commentary on Twitter
🚨A must read – out now in JCF: Position Statement on Endomyocardial Biopsy 🫀 – @HFSA @escardio @ESCardioNews #CardioTwitter #FunctionNotFailure #HeartSuccess @rcstarling @MRMehraMD @BiykemB @Filippatos @robmentz @dranulala https://t.co/33FPZDBviN pic.twitter.com/VJEzGLIRIg
— Journal of Cardiac Failure (@JCardFail) July 21, 2021
Review: Ethics in extracorporeal life support.
23 Jul, 2021 | 10:29h | UTCEthics in extracorporeal life support: a narrative review – Critical Care


